AMRN · NASDAQ
Amarin (AMRN) Stock Price & Fundamentals
Amarin (AMRN) closed at $728.00 on Oct 9, 2026, down 0.45% from the previous close of $731.30.
Share price, past year
1Y +30.58%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $728.00 |
| Sep 30, 2026 | $743.31 |
| Aug 31, 2026 | $717.29 |
| Jul 31, 2026 | $646.82 |
| Jun 30, 2026 | $666.30 |
| May 29, 2026 | $648.27 |
| Apr 30, 2026 | $627.67 |
| Mar 31, 2026 | $613.33 |
| Feb 27, 2026 | $593.63 |
| Jan 30, 2026 | $631.96 |
| Dec 31, 2025 | $658.00 |
| Nov 28, 2025 | $654.90 |
| Oct 31, 2025 | $584.12 |
Key statistics
- Market cap
- $305.79B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.07
- Revenue (TTM)
- $186.23M
- Net income (TTM)
- −$27.12M
- Shares outstanding
- 420M
- Dividend yield
- —
- 52-week range
- $552.32 – $749.40
Amarin's market cap is $305.79B, based on a share price of $728.00 and 420M shares outstanding as of Jun 30, 2026.
Financials
Amarin reported revenue of $213.65M for fiscal 2025, down 6.55% from fiscal 2024.
Amarin reported a net loss of $38.80M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $213.65M | −6.6% | −$38.80M | −18.2% | −$0.09 | — |
| FY2024ended Dec 31, 2024 | $228.61M | −25.5% | −$82.18M | −36.0% | −$0.20 | — |
| FY2023ended Dec 31, 2023 | $306.91M | −16.9% | −$59.11M | −19.3% | −$0.15 | — |
| FY2022ended Dec 31, 2022 | $369.19M | −36.7% | −$105.80M | −28.7% | −$0.26 | — |
| FY2021ended Dec 31, 2021 | $583.19M | −5.0% | $7.73M | 1.3% | $0.02 | — |
| FY2020ended Dec 31, 2020 | $614.06M | +42.9% | −$18.00M | −2.9% | −$0.05 | −$22.00M |
| FY2019ended Dec 31, 2019 | $429.76M | +87.5% | −$22.65M | −5.3% | −$0.07 | −$11.84M |
| FY2018ended Dec 31, 2018 | $229.21M | +26.6% | −$116.45M | −50.8% | −$0.39 | −$94.76M |
| FY2017ended Dec 31, 2017 | $181.10M | +39.2% | −$67.87M | −37.5% | −$0.25 | −$32.85M |
| FY2016ended Dec 31, 2016 | $130.08M | — | −$86.35M | −66.4% | −$0.41 | −$71.84M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $42.21M | −$7.65M | −$0.02 |
| Q1 FY2026ended Mar 31, 2026 | $45.13M | −$10.51M | −$0.03 |
| Q4 FY2025ended Dec 31, 2025 | $49.22M | −$1.22M | $0.00 |
| Q3 FY2025ended Sep 30, 2025 | $49.67M | −$7.74M | −$0.02 |
| Q2 FY2025ended Jun 30, 2025 | $72.74M | −$14.14M | −$0.03 |
| Q1 FY2025ended Mar 31, 2025 | $42.02M | −$15.70M | −$0.04 |
| Q4 FY2024ended Dec 31, 2024 | $62.31M | −$48.62M | −$0.12 |
| Q3 FY2024ended Sep 30, 2024 | $42.30M | −$25.13M | −$0.06 |
Company profile
- Name
- Amarin Corporation plc
- Ticker
- AMRN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- Spaces South Docklands, Block C, 77 Sir John Rogerson'S Quay, Dublin 2
- Incorporated in
- X0
- Fiscal year ends
- December
- SEC CIK
- 0000897448
Recent SEC filings
- Jul 29, 2026
- Jul 29, 2026
- May 15, 2026
- Apr 29, 2026
- Apr 29, 2026
- Mar 27, 2026
- Mar 2, 2026
- Feb 25, 2026
Frequently asked questions
What is Amarin's stock price?
Amarin (AMRN) closed at $728.00 on Oct 9, 2026, down 0.45% from the previous close of $731.30.
What is Amarin's market cap?
Amarin's market cap is $305.79B, based on a share price of $728.00 and 420M shares outstanding as of Jun 30, 2026.
How much revenue does Amarin make?
Amarin reported revenue of $213.65M for fiscal 2025, down 6.55% from fiscal 2024.
Does Amarin pay a dividend?
Amarin's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Amarin Corporation plc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures